| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.00012 | 1 |